自身免疫病孕妇接种疫苗与COVID-19结局的全国回顾性队列分析
该回顾性全国队列纳入270,811例孕妇,其中4,715例(1.5%)患有至少一种自身免疫风湿病(AIRDs)。初始接种在Omicron前时期延迟AIRDs患者COVID-19发生时间,但Omicron时期无显著保护;与无AIRDs的接种者相比,AIRDs患者突破感染和重症风险更高。
要点
- AIRDs孕妇初始接种在Omicron前延迟COVID-19,Omicron期无显著保护。
- 加强针对AIRDs孕妇感染和重症均无显著保护。
- 相比无AIRDs接种者,AIRDs孕妇突破感染和Omicron重症风险更高。
核心结论
- 疫苗接种与孕妇COVID-19保护相关,但在AIRDs患者中效力降低,尤其Omicron时期。
研究设计与样本
- 全国电子健康记录回顾性队列,纳入2020年12月10日至2024年6月1日间妊娠的15至55岁孕妇270,811例。
- 其中4,715例(1.5%)患有至少一种AIRDs(类风湿关节炎、脊柱关节炎或系统性红斑狼疮)。
- 按AIRD和接种状态(未接种、初始接种或加强接种)分组,采用调整时间比(TR)评估至COVID-19发生和重症的时间,并按变异时期(Omicron前 vs Omicron)分层。
主要发现
- AIRDs患者初始接种在Omicron前时期延迟COVID-19发生(TR:1.095;95%CI:1.036-1.157),Omicron时期无显著保护(TR:1.039;95%CI:0.980-1.102)。
- 加强针对感染无显著保护(TR:1.039;95%CI:0.958-1.128),对重症也无显著保护(TR:1.119;95%CI:0.670-1.867)。
- 相比无AIRDs的接种者,AIRDs患者突破感染时间更短:Omicron前(TR:0.940;95%CI:0.891-0.991)和Omicron期(TR:0.905;95%CI:0.858-0.955)。
- AIRDs患者在Omicron期重症时间更短(TR:0.631;95%CI:0.485-0.821)。
临床怎么用
- AIRDs孕妇接种COVID-19疫苗仍可能获益,但应告知其保护效力可能降低,尤其Omicron时期。
- 对AIRDs孕妇需加强突破感染和重症监测,不能仅依赖疫苗接种状态评估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effectiveness of COVID-19 vaccination in reducing incident and severe COVID-19 among pregnant individuals with autoimmune rheumatic diseases (AIRDs). METHODS: We conducted a retrospective cohort study using national electronic health records, including 270,811 pregnant individuals aged 15 to 55 years with pregnancies between December 10, 2020, and June 1, 2024. Among them, 4,715 (1.5%) had at least one AIRD (rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus). Participants were categorized by AIRD and vaccination status (unvaccinated, initially vaccinated, or booster vaccinated). Time to incident and severe COVID-19 was assessed using adjusted time ratios (TRs), stratified by variant period (pre-Omicron vs Omicron). RESULTS: Initial vaccination delayed time to COVID-19 during the pre-Omicron period in individuals with AIRDs (TR: 1.095; 95% confidence interval [CI]: 1.036-1.157) but not during Omicron (TR: 1.039; 95% CI: 0.980-1.102). Booster vaccination was not significantly protective against infection (TR: 1.039; 95% CI: 0.958-1.128) or severe outcomes (TR: 1.119; 95% CI: 0.670-1.867). Compared to vaccinated individuals without AIRDs, those with AIRDs had shorter time to breakthrough infections in both pre-Omicron (TR: 0.940; 95% CI: 0.891-0.991) and Omicron (TR: 0.905; 95% CI: 0.858-0.955) periods and to severe disease during Omicron (TR: 0.631; 95% CI: 0.485-0.821). CONCLUSION: Vaccination is associated with protection against COVID-19 in pregnancy, but its effectiveness is reduced in those with AIRDs, particularly during the Omicron period.
引用
- Jaferian S, Wilkins K, Qin Q, et al. Association of Vaccination With COVID Outcomes in Pregnant People With Autoimmune Diseases: A Retrospective National Cohort Analysis. Arthritis Care Res (Hoboken). 2026. PMID: 41972809. doi:10.1002/acr.80063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。